Current Molecular Imaging (Discontinued)

Abass Alavi
Department of Radiology/Nuclear Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA 19104
USA
Email: abass.alavi@uphs.upenn.edu

Back

Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

Author(s): Chun-Kai Fang, Ya-Fang Chang, Hui-Yen Chuang, Hong-Wen Chen, Jeng-Jong Hwang.

Abstract:

Both neuropsychiatric disorders and malignancies of central nervous system (CNS) represent a significant health burden and life-threatening diseases worldwide. Radiotracer-based neuroimaging is an attractive tool that permits the in vivo detection and characterization of metabolic and molecular processes which are fundamental elements for brain function, and improves the theranostics of brain diseases and disorders.

In this review, we outlined the new development of molecular imaging probes for dopamine and serotonin systems in neuropsychiatry and boron neutron capture therapy (BNCT) for brain tumors in neuro-oncology with positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

Keywords: Boron neutron capture therapy, dopamine, molecular imaging, positron emission tomography, serotonin, singlephoton emission computed tomography.

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

VOLUME: 3
ISSUE: 1
Year: 2014
Page: [15 - 26]
Pages: 12
DOI: 10.2174/15748855113089990013